Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Leuk Lymphoma. 2017 Jul 18;59(4):821–828. doi: 10.1080/10428194.2017.1352089

Table 2.

Univariate and multivariate analyses for overall survival.

Hazard ratio 95% CI p value
Variable (univariate)
  CD25 (pos versus neg) 2.02 1.06 3.82 .03
Variable (multivariable)
  Remission (CR/CRi versus none) 0.32 0.16 0.64 .001
  ASXL1 (mutated versus wild type) 2.47 1.09 5.64 .030
  TET2 (mutated versus wild type) 2.30 1.14 4.63 .020

Pos: positive; neg: negative; CR: complete remission; Cri: complete remission with incomplete recovery.